Your browser doesn't support javascript.
loading
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.
Simuni, Tanya; Fiske, Brian; Merchant, Kalpana; Coffey, Christopher S; Klingner, Elizabeth; Caspell-Garcia, Chelsea; Lafontant, David-Erick; Matthews, Helen; Wyse, Richard K; Brundin, Patrik; Simon, David K; Schwarzschild, Michael; Weiner, David; Adams, Jamie; Venuto, Charles; Dawson, Ted M; Baker, Liana; Kostrzebski, Melissa; Ward, Tina; Rafaloff, Gary.
Afiliação
  • Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Fiske B; Research Programs, Michael J. Fox Foundation for Parkinson's Research, New York, New York.
  • Merchant K; Department of Neurology, Northwestern University, Chicago, Illinois.
  • Coffey CS; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City.
  • Klingner E; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City.
  • Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City.
  • Lafontant DE; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City.
  • Matthews H; The Cure Parkinson's Trust, London, England.
  • Wyse RK; Research and Development, The Cure Parkinson's Trust, London, England.
  • Brundin P; Van Andel Institute, Center for Neurodegenerative Science, Grand Rapids, Michigan.
  • Simon DK; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Schwarzschild M; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
  • Weiner D; Consultant, Austin, Texas.
  • Adams J; Department of Neurology, University of Rochester, Rochester, New York.
  • Venuto C; CHET CTCC, University of Rochester, Rochester, New York.
  • Dawson TM; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Baker L; CHET CTCC, University of Rochester, Rochester, New York.
  • Kostrzebski M; CHET CTCC, University of Rochester, Rochester, New York.
  • Ward T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Rafaloff G; Steven's Institute of Technology, Marlboro, New Jersey.
JAMA Neurol ; 78(3): 312-320, 2021 03 01.
Article em En | MEDLINE | ID: mdl-33315105
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Pirimidinas / Proteínas Tirosina Quinases / Progressão da Doença Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Pirimidinas / Proteínas Tirosina Quinases / Progressão da Doença Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos